monoethylglycinexylidide has been researched along with erythromycin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cakaloglu, Y; Devlin, J; Tredger, JM; Williams, R | 1 |
Watkins, PB | 1 |
Isohanni, MH; Neuvonen, PJ; Olkkola, KT | 2 |
Backman, JT; Kivistö, KT; Neuvonen, PJ; Taavitsainen, P; Wang, JS; Wen, X | 1 |
Danhof, M; Groeneveld, AB; Swart, EL; Touw, DJ; van der Hoven, B | 1 |
1 review(s) available for monoethylglycinexylidide and erythromycin
Article | Year |
---|---|
Noninvasive tests of CYP3A enzymes.
Topics: Animals; Breath Tests; Cytochrome P-450 Enzyme System; Dapsone; Erythromycin; Humans; Hydrocortisone; Lidocaine; Liver; Midazolam; Nifedipine | 1994 |
2 trial(s) available for monoethylglycinexylidide and erythromycin
Article | Year |
---|---|
Effect of erythromycin and itraconazole on the pharmacokinetics of oral lignocaine.
Topics: Administration, Oral; Adult; Anesthetics, Local; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Double-Blind Method; Drug Interactions; Erythromycin; Female; Humans; Itraconazole; Lidocaine; Male; Mixed Function Oxygenases; Placebos; Protein Synthesis Inhibitors | 1999 |
Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaine.
Topics: Administration, Oral; Adult; Anesthetics, Local; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Erythromycin; Female; Fluvoxamine; Half-Life; Humans; Lidocaine; Male; Metabolic Clearance Rate; Nausea | 2006 |
3 other study(ies) available for monoethylglycinexylidide and erythromycin
Article | Year |
---|---|
Importance of cytochrome P-450IIIA activity in determining dosage and blood levels of FK 506 and cyclosporine in liver transplant recipients.
Topics: Aryl Hydrocarbon Hydroxylases; Breath Tests; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Erythromycin; Female; Humans; Lidocaine; Liver Transplantation; Male; Oxidoreductases, N-Demethylating; Predictive Value of Tests; Regression Analysis; Tacrolimus | 1994 |
Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro.
Topics: Anesthetics, Local; Autopsy; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erythromycin; Fluvoxamine; Humans; In Vitro Techniques; Ketoconazole; Lidocaine; Male; Microsomes, Liver; Middle Aged; Mixed Function Oxygenases | 1999 |
Correlation between midazolam and lignocaine pharmacokinetics and MEGX formation in healthy volunteers.
Topics: Adult; Drug Interactions; Erythromycin; Female; Humans; Hypnotics and Sedatives; Lidocaine; Liver Function Tests; Male; Midazolam; Time Factors | 2002 |